Company: NGVT
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001653477-25-000127
Chunk: 43

Company: Ingevity Corp
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 43
---
 and make informed and consistent resource allocation decisions.The historical industrial specialties product line that is classified as discontinued operations includes only direct operating expenses which the Company will no longer incur upon the close of the Divestiture. Indirect costs, such as those related to corporate and shared service functions previously allocated to the industrial specialties product line, do not meet the criteria for discontinued operations and remain reported within continuing operations in Indirect costs allocated to Divestiture. Three Months Ended September 30,Nine Months Ended September 30,In millions2025202420252024Segment EBITDA (1)(2)Performance Materials$79.9 $80.6 $236.1 $240.8 Performance Chemicals24.8 24.3 55.1 45.3 Advanced Polymer Technologies9.9 9.8 23.3 29.1 Total Segment EBITDA (1)(2)$114.6 $114.7 $314.5 $315.2 Interest expense, net(18.4)(23.8)(56.4)(69.3)(Provision) benefit for income taxes on continuing operations(21.4)(6.5)(34.8)23.6 Depreciation and amortization(27.7)(25.2)(77.4)(75.0)Restructuring and other income (charges), net (3)(1.0)(3.3)(10.1)(8.3)Goodwill impairment charge (4)— — (183.8)(306.6)Acquisition and other-related income (costs), net (5)— 0.1 — — Gain (loss) on strategic investments (6)— (2.2)(2.5)(2.1)Proxy contest charges (7)— — (8.2)— Portfolio review expenses (8)(1.1)— (1.1)— Indirect costs allocated to Divestiture (9)(4.2)(6.3)(11.7)(18.5)Net income (loss) from continuing operations$40.8 $47.5 $(71.5)$(141.0)_______________(1) Segment EBITDA is defined as segment net sales less segment operating expenses (segment operating expenses consist of costs of sales, selling, general and administrative expenses, research and technical expenses, other (income) expense, net, excluding depreciation